Unknown

Dataset Information

0

Enhanced Intracellular Delivery of BCG Cell Wall Skeleton into Bladder Cancer Cells Using Liposomes Functionalized with Folic Acid and Pep-1 Peptide.


ABSTRACT: Although bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) might function as a potential substitute for live BCG, its use in the treatment of bladder cancer remains limited owing to issues such as insolubility and micrometer-size following exposure to an aqueous environment. Thus, to develop a novel nanoparticulate system for efficient BCG-CWS delivery, liposomal encapsulation was carried out using a modified emulsification-solvent evaporation method (targets: Size, <200 nm; encapsulation efficiency, ~60%). Further, the liposomal surface was functionalized with specific ligands, folic acid (FA), and Pep-1 peptide (Pep1), as targeting and cell-penetrating moieties, respectively. Functionalized liposomes greatly increased the intracellular uptake of BCG-CWS in the bladder cancer cell lines, 5637 and MBT2. The immunoactivity was verified through elevated cytokine production and a THP-1 migration assay. In vivo antitumor efficacy revealed that the BCG-CWS-loaded liposomes effectively inhibited tumor growth in mice bearing MBT2 tumors. Dual ligand-functionalized liposome was also superior to single ligand-functionalized liposomes. Immunohistochemistry supported the enhanced antitumor effect of BCG-CWS, with IL-6 production and CD4 infiltration. Thus, we conclude that FA- and Pep1-modified liposomes encapsulating BCG-CWS might be a good candidate for bladder cancer treatment with high target selectivity.

SUBMITTER: Yoon HY 

PROVIDER: S-EPMC6970232 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4445741 | BioStudies
2017-01-01 | S-EPMC5666455 | BioStudies
1000-01-01 | S-EPMC4094575 | BioStudies
2019-01-01 | S-EPMC6407753 | BioStudies
2016-01-01 | S-EPMC4810226 | BioStudies
2004-01-01 | S-EPMC321570 | BioStudies
2018-01-01 | S-EPMC6215598 | BioStudies
2012-01-01 | S-EPMC4943321 | BioStudies
2020-01-01 | S-EPMC7465306 | BioStudies
1000-01-01 | S-EPMC3260950 | BioStudies